228
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Factors associated with concurrent illicit use of opiates and crack/cocaine among opiate-users in treatment: implications for treatment services in England

, , , &
Pages 298-304 | Received 19 Oct 2018, Accepted 19 Jul 2019, Published online: 01 Aug 2019

References

  • Alaja R, Seppa K, Sillanaukee P, Tienari P, Huyse FJ, Herzog T, Malt UF, Lobo A. 1997. Psychiatric referrals associated with substance use disorders: prevalence and gender differences. Alcohol Clin Exp Res. 21:620–626.
  • Anglin MD, Hser YI, Grella CE. 1997. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 11(4):308–323.
  • Best DW, Ghufran S, Day E, Ray R, Loaring J, Breaking the habit 2008. A retrospective analysis of desistance factors among formerly problematic heroin users. Drug Alcohol Rev. 27(6):619–624.
  • Best D, Gossop M, Stewart D, Marsden J, Lehmann P, Strang J. 1999. Continued heroin use during methadone treatment: relationships between frequency of use and reasons reported for heroin use. Drug Alcohol Rev. 53(3):191–195.
  • Best D, Gow J, Taylor A, Knox T, Groshkova T, White W. 2012. Mapping the recovery stories of drinkers and drug users in glasgow: quality of life and its associations with measures of recovery capital. Drug Alcohol Rev. 31(3):334–341.
  • Best D, Groshkova T, Sadler J, Day E, White W. 2011. What is recovery? Functioning and recovery stories of self-identified people in recovery in a service users’ group and their peer networks in Birmingham England. Alcoholism Treat Quart. 29(3):293–313.
  • Beswick T, Best D, Rees S, Coomber R, Gossop M, Strang J. 2001. Multiple drug use: patterns and practices of heroin and crack use in a population of opiate addicts in treatment. Drug Alc Rev. 20(2):201–204.
  • Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB. 1998. RESEARCH REPORT A meta‐analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction. 93(1):73–92.
  • Chung T. 2006. Does Adolescents’ readiness to change substance use behavior differ depending on profile of psychiatric comorbidity? J Dual Diagn. 2(1):73–88.
  • Cloud W, Granfield R. 2008. Conceptualising recovery capital: Expansion of a theoretical construct. Subst Use Misuse. 43(12–13):1971–1986.
  • Craig T, Hodson S. 2000. Homeless youth in London: II. Accommodation, employment and health outcomes at 1 year. Psychol Med. 30(1):187–194.
  • Darke S, Ross J, Mills KL, Williamson A, Havard A, Teesson M. 2007. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS). Addict Behav. 32(9):1897–1906.
  • Darke S, Ross J, Teesson M, Ali R, Cooke R, Ritter A, Lynskey M. 2005. Factors associated with 12 months continuous heroin abstinence: Findings from the Australian treatment outcome study (ATOS). J Subst Abuse Treat. 28(3):255–263.
  • Donovan D, Mattson ME, Cisler RA, Longbaugh R, Zweben A. 2005. Quality of life as an outcome measure in alcoholism treatment research. J Stud Alcohol Suppl. 66:119–139.
  • Gossop M, Marsden J, Stewart D, Kidd T. 2003. The national treatment outcome research study (NTORS) (2003), 4-5 year follow-up results. Addiction. 98(3):291–303.
  • Gossop M, Marsden J, Stewart D, Treacy S. 2002. Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK). Addict Behav. 27(2):155–166.
  • Grella CE, Anglin MD, Wugalter SE. 1997. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Am J Drug Alcohol Ab. 23(1):15–42.
  • Grella CE, Hser Y-I, Joshi V, Rounds-Bryant J. 2001. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis. 189(6):384–392.
  • Hammersley R, Psychol C, Pearl S. 2007. Drug use and other problems of residents in projects for the young single Homeless. Health Soc Care Comm. 4(4):193–199.
  • Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS, Friedland GH. 1995. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health. 85(1):83–88.
  • Heidebrecht F, MacLeod M, Dawkins L. 2018. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack. Addict Behav. 77:210–216.
  • Hser Y-I. 2007. Predicting Long-Term Stable Recovery from Heroin addiction: findings from a 33-year follow-up study. J Addict Dis. 26(1):51–60.
  • Hser YI, Anglin MD, Fletcher B. 1998. Comparative treatment effectiveness: Effects of program modality and client drug dependence history on drug use reduction. J Subst Abuse Treat. 15(6):513–523.
  • Hubbard RL, Craddock SG, Anderson J. 2003. Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 25(3):125–134.
  • Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. 1997. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 11(4):261.
  • Jones A, Donmall M, Millar T, Moody A, Weston S, Anderson T, Gittens M, Abeywardana V, D'Souza J. 2009. The Drug Treatment Outcomes Research Study (DTORS): Final Outcomes Report [UK] Home Office Research Report, 2009.
  • Kaminer Y, Tarter RE, Bukstein OG, Kabene M. 1992. Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. J Am Acad Child Adolesc Psychiat. 31(6):1046–1049.
  • Kazemian L. 2007. Desistance from crime: Theoretical, empirical, methodological and policy considerations. J Contemp Crim Just. 23(1):5–27.
  • Laudet AB. 2007. What does recovery mean to you? Lessons from the recovery experience for research and practice. J Subst Abuse Treat. 33(3):243–256.
  • Laudet AB, White W. 2010. What are your priorities right now? Identifying service needs across recovery stages to inform service development. J Subst Abuse Treat. 38(1):51–59.
  • Levinson I, Galynker II, Rosenthal RN. 1994. Methadone withdrawal psychosis. Biol Psychiat. 35(9):692.
  • Litt MD, Kadden RM, Cooney NL, Kabela E. 2003. Coping skills and treatment outcomes in cognitive-behavioral and interactional group therapy for alcoholism. J Consult Clin Psych. 71(1):118–128.
  • Maremmani I, Perugi P, Pacini M, Akiskal HS. 2006. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J Affect Disorders. 93(1–3):1–12.
  • Marsden J, Farrell M, Bradbury C, Dale-Perera A, Eastwood B, Roxburgh M, Taylor S. 2008. Development of the Treatment Outcomes Profile. Addiction. 103(9):1450–1460.
  • Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. 2000. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 176:285–289.
  • Marsden J, Eastwood B, Ali R, Burkinshaw P, Chohan G, Copello A, Burn D, Kelleher M, Mitcheson L, Taylor S, et al. 2014. Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT). Drug Alcohol Depend. 139:121–131.
  • Mattick RP, Breen C, Kimber J, Davoli M. 2014. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Db Syst Rev (2):CD002207.
  • McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O'Brien CP. 1997. Problem-service'matching'in addiction treatment: a prospective study in 4 programs. Arch Gen Psychiatry. 54(8):730–735.
  • National Treatment Agency. 2012. Medications in recovery: re-orientating drug dependence, London.
  • Pattoni L. 2012. Strengths-based approaches for working with individuals. IRISS
  • Pierce M, Hayhurst K, Bird SM, Hickman M, Seddon T, Dunn G, Millar T. 2015. Quantifying crime associated with drug use among a large cohort of sanctioned offenders in England and Wales. Drug Alcohol Depend. 155:52–59.
  • Reid P, Klee H. 1999. Young homeless people and service provision. Health Soc Care Comm. 7(1):17–24.
  • Rudolf H, Watts J. 2002. Quality of life in substance abuse and dependency. Int Rev Psychiatr. 14(3):190–197.
  • Sampson RJ, Laub JH. 1993. Crime in the making: pathways and turning points through life. London (UK): Harvard University Press.
  • Senbanjo R, Wolff KIM, Marshall E, Strang J. 2009. Persistence of heroin use despite methadone treatment: poor coping self‐efficacy predicts continued heroin use. Drug Alcohol Rev. 28(6):608–615.
  • Sihvola E, Rose R, Dick D, Pulkkinen L, Marttunen M, Kaprio J. 2008. Early-onset depressive disorders predict the use of addictive substances in adolescence: a prospective study of adolescent Finnish twins. Addiction. 103(12):2045–2053.
  • Simpson DD, Joe GW, Rowan-Szal GA. 1997. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depen. 47(3):227–235.
  • Simpson DD, Sells SB. 1990. Opioid addiction and treatment: A 12-year follow-up. Malabar (FL): Krieger.
  • Stein MD. 1990. Medical complications of intravenous drug use. J Gen Intern Med. 5(3):249–257.
  • Teesson M, Mills K, Ross J, Darke S, Williamson A, Havard A. 2008. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction. 103(1):80–88.
  • Thornton CC, Gottheil E, Weinstein SP, Kerachsky RS. 1998. Patient-treatment matching in substance abuse: drug addiction severity. J Subst Abuse Treat. 15(6):505–511.
  • Timko C, Sempel JM. 2004. Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity. J Subst Abuse Treat. 26(3):209–218.
  • Timpson H, Eckley L, Sumnall H, Pendlebury M, Hay G. 2016. Once you've been there, you're always recovering”: exploring experiences, outcomes, and benefits of substance misuse recovery. Drugs and Alcohol Today. 16(1):29–38.
  • Verheual R, Brink W. 2005. Causal pathways between substance use disorders and personality pathology. Aust Psychol. 40:127–136.
  • Winters KC. 1999. Treating adolescents with substance use disorders: an overview of practice issues and treatment outcome. Subst Abus. 20(4):203–225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.